243 related articles for article (PubMed ID: 11460890)
1. Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment.
Brambilla F
CNS Drugs; 2001; 15(2):119-36. PubMed ID: 11460890
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity.
Holden RJ; Pakula IS
Med Hypotheses; 1996 Dec; 47(6):423-38. PubMed ID: 8961238
[TBL] [Abstract][Full Text] [Related]
3. Impaired cholecystokinin secretion in bulimia nervosa.
Geracioti TD; Liddle RA
N Engl J Med; 1988 Sep; 319(11):683-8. PubMed ID: 3412386
[TBL] [Abstract][Full Text] [Related]
4. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
[TBL] [Abstract][Full Text] [Related]
5. Neurochemistry of bulimia nervosa.
Kaye WH; Weltzin TE
J Clin Psychiatry; 1991 Oct; 52 Suppl():21-8. PubMed ID: 1682306
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa.
Keel PK; Wolfe BE; Liddle RA; De Young KP; Jimerson DC
Arch Gen Psychiatry; 2007 Sep; 64(9):1058-66. PubMed ID: 17768271
[TBL] [Abstract][Full Text] [Related]
7. Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjects.
Demitrack MA; Kalogeras KT; Altemus M; Pigott TA; Listwak SJ; Gold PW
J Clin Endocrinol Metab; 1992 Jun; 74(6):1277-83. PubMed ID: 1592871
[TBL] [Abstract][Full Text] [Related]
8. Assessment and treatment of bulimia nervosa.
Mcgilley BM; Pryor TL
Am Fam Physician; 1998 Jun; 57(11):2743-50. PubMed ID: 9636337
[TBL] [Abstract][Full Text] [Related]
9. [Selected issues of biological aspects of eating disorders].
Włodarczyk-Bisaga K; Bisaga A
Psychiatr Pol; 1994; 28(5):579-91. PubMed ID: 7991711
[TBL] [Abstract][Full Text] [Related]
10. [Comorbidity of eating disorders and bipolar affective disorders].
Kamińska K; Rybakowski F
Psychiatr Pol; 2006; 40(3):455-67. PubMed ID: 17037812
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical abnormalities of anorexia nervosa and bulimia nervosa.
Fava M; Copeland PM; Schweiger U; Herzog DB
Am J Psychiatry; 1989 Aug; 146(8):963-71. PubMed ID: 2568763
[TBL] [Abstract][Full Text] [Related]
12. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
Palavras MA; Hay P; Touyz S; Sainsbury A; da Luz F; Swinbourne J; Estella NM; Claudino A
Trials; 2015 Dec; 16():578. PubMed ID: 26683478
[TBL] [Abstract][Full Text] [Related]
13. Research update on serotonin function in bulimia nervosa and anorexia nervosa.
Wolfe BE; Metzger E; Jimerson DC
Psychopharmacol Bull; 1997; 33(3):345-54. PubMed ID: 9550877
[TBL] [Abstract][Full Text] [Related]
14. The role of serotonin in eating disorders.
Leibowitz SF
Drugs; 1990; 39 Suppl 3():33-48. PubMed ID: 2197074
[TBL] [Abstract][Full Text] [Related]
15. [Triggers of bulimia and compulsion attacks: validation of the "Start" questionnaire].
Rigaud D; Jiang T; Pennacchio H; Brémont M; Perrin D
Encephale; 2014 Sep; 40(4):323-9. PubMed ID: 24091068
[TBL] [Abstract][Full Text] [Related]
16. [Comorbidity of bipolar and eating disorders. Epidemiologic and therapeutic aspects].
Mury M; Verdoux H; Bourgeois M
Encephale; 1995; 21(5):545-53. PubMed ID: 8529563
[TBL] [Abstract][Full Text] [Related]
17. Serotonin function following remission from bulimia nervosa.
Wolfe BE; Metzger ED; Levine JM; Finkelstein DM; Cooper TB; Jimerson DC
Neuropsychopharmacology; 2000 Mar; 22(3):257-63. PubMed ID: 10693153
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bulimia nervosa with ondansetron.
Fung SM; Ferrill MJ
Ann Pharmacother; 2001 Oct; 35(10):1270-3. PubMed ID: 11675858
[TBL] [Abstract][Full Text] [Related]
19. Eating disorders in females: genetics, pathophysiology, and treatment.
Halmi KA
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1379-86. PubMed ID: 12510994
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptides in eating disorders.
Jimerson DC; Wolfe BE
CNS Spectr; 2004 Jul; 9(7):516-22. PubMed ID: 15208511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
